Astec Lifesciences Ltd
ASTECAstec Lifesciences Ltd
ASTEC
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -30.01 | 6.37 | 0.12% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 31.64 | 3.63 | 1.25% |
Forecast & Ratings
Detailed Forecast from 2 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Astec LifeSciences Limited is a holding company. The Company is a producer of agrochemicals and pharmaceutical intermediates.
Peers
Compare with peersFertilisers And Chemicals Travancore Ltd
Coromandel International Ltd
UPL Ltd
Bayer Cropscience Ltd
Chambal Fertilisers and Chemicals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 240.19 | 301.53 | 395.02 | 442.06 | 534.54 | 562.79 | 687.04 | 641.23 | 463.82 | 389.57 | ||||||||||
Raw Materials | 160.59 | 179.66 | 224.22 | 295.05 | 333.81 | 344.60 | 444.82 | 460.83 | 318.82 | 440.01 | ||||||||||
| Power & Fuel Cost | 13.84 | 15.75 | 17.87 | 23.80 | 28.80 | 25.28 | 38.04 | 45.68 | 35.87 | |||||||||||
| Employee Cost | 15.89 | 20.38 | 21.71 | 25.10 | 29.92 | 38.35 | 50.31 | 52.26 | 61.74 | |||||||||||
| Selling & Administrative Expenses | 15.62 | 13.65 | 16.74 | 15.41 | 21.83 | 17.17 | 23.55 | 25.77 | 20.97 | |||||||||||
| Operating & Other expenses | -1.38 | 17.44 | 33.43 | -4.93 | 23.07 | 17.92 | -34.22 | -32.63 | 26.69 | |||||||||||
EBITDA | 35.63 | 54.65 | 81.05 | 87.63 | 97.11 | 119.47 | 164.54 | 89.32 | -0.27 | -50.44 | ||||||||||
| Depreciation/Amortization | 10.40 | 13.68 | 14.68 | 19.35 | 23.16 | 25.66 | 34.36 | 33.65 | 36.25 | 36.14 | ||||||||||
| PBIT | 25.23 | 40.97 | 66.37 | 68.28 | 73.95 | 93.81 | 130.18 | 55.67 | -36.52 | -86.58 | ||||||||||
| Interest & Other Items | 12.81 | 12.24 | 10.66 | 12.38 | 12.59 | 4.75 | 9.06 | 20.71 | 25.23 | 25.79 | ||||||||||
| PBT | 12.42 | 28.73 | 55.71 | 55.90 | 61.36 | 89.06 | 121.12 | 34.96 | -61.75 | -112.37 | ||||||||||
| Taxes & Other Items | 7.46 | 9.62 | 20.81 | 20.17 | 13.84 | 24.02 | 31.26 | 9.39 | -14.81 | -33.91 | ||||||||||
| Net Income | 4.96 | 19.11 | 34.90 | 35.73 | 47.52 | 65.04 | 89.86 | 25.57 | -46.94 | -78.46 | ||||||||||
| EPS | 2.55 | 9.81 | 17.88 | 18.29 | 24.29 | 33.22 | 45.86 | 13.04 | -23.94 | -40.01 | ||||||||||
| DPS | 0.00 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | ||||||||||
| Payout ratio | 0.00 | 0.15 | 0.08 | 0.08 | 0.06 | 0.05 | 0.03 | 0.11 | — | -0.04 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
MaterialsFertilizers & Agro Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Astec Lifesciences Ltd | -50.17 | 6.37 | 0.12% |
| Fertilisers And Chemicals Travancore Ltd | 427.43 | 49.05 | — |
| Coromandel International Ltd | 30.93 | 5.38 | 0.35% |
| UPL Ltd | -36.14 | 1.33 | 0.17% |
Price Comparison
Compare ASTEC with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 2.30%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Decreased Mutual Fund Holding
In last 3 months, mutual fund holding of the company has decreased by 4.74%
Top 5 Mutual Funds holding Astec Lifesciences Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Nippon India Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.2461% | Percentage of the fund’s portfolio invested in the stock 0.09% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 213/226 (-23) |
TATA ASSET MANAGEMENT LTD#TATA MF-TATA RETIREMENT SAVINGS FUND-PROGRESSIVE-DIRECT PLAN-GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.8499% | Percentage of the fund’s portfolio invested in the stock 1.00% | Change in the portfolio weight of the stock over the last 3 months 1.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 30/70 (+3) |
ICICI Prudential Commodities Fund - Cumulative - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.5700% | Percentage of the fund’s portfolio invested in the stock 0.52% | Change in the portfolio weight of the stock over the last 3 months -0.11% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 36/50 (-5) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
ASTEC has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.12%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.25 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 21, 2023
Dividend/Share
₹1.50
Ex DateEx Date
Jul 21, 2023
Cash Dividend
Ex DateEx DateJul 19, 2022
Dividend/Share
₹1.50
Ex DateEx Date
Jul 19, 2022
Cash Dividend
Ex DateEx DateJul 22, 2021
Dividend/Share
₹1.50
Ex DateEx Date
Jul 22, 2021
Cash Dividend
Ex DateEx DateJul 16, 2020
Dividend/Share
₹1.50
Ex DateEx Date
Jul 16, 2020
Cash Dividend
Ex DateEx DateJul 18, 2019
Dividend/Share
₹1.50
Ex DateEx Date
Jul 18, 2019
Astec Lifesciences reports consolidated net loss of Rs 39.72 crore in the June 2024 quarter
Net Loss of Astec Lifesciences reported to Rs 39.72 crore in the quarter ended June 2024 as against net loss of Rs 8.19 crore during the previous quarter ended June 2023. Sales declined 51.44% to Rs 69.37 crore in the quarter ended June 2024 as against Rs 142.85 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales69.37142.85 -51 OPM %-66.672.19 - PBDT-52.37-1.62 -3133 PBT-61.64-11.01 -460 NP-39.72-8.19 -385 Powered by Capital Market - Live
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 29 July 2024.Powered by Capital Market - Live
Astec LifeSciences sinks 11% as Q4 earnings take a knock
Astec LifeSciences tumbles 10% on loss in Q4; stock down 44% in six months
Astec LifeSciences launches R&D centre in Maharashtra
Astec Lifesciences zooms 37% in two days on heavy volumes
Capri Global Capital Ltd leads losers in ‘A’ group
Astec LifeSciences receives ratings action from ICRA
Astec Lifesciences shares tank 14% after Q3 results
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 0.97%, vs industry avg of 10.38%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.34% to 0.22%